Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarina Bremme

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Lakartidningen|January 29, 2020
[Program for clinical care of immune thrombocytopenic purpura in pregnancy]Gisela Wegnelius, Katarina Bremme, Pelle Lindqvist
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 3, 2015
Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsiaThomas Kahan, Katarina Bremme, Eva Östlund
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 12, 2018
Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practiceGisela Wegnelius, Katarina Bremme, Pelle G Lindqvist, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 15, 2011
Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolismPelle G Lindqvist, Katarina Bremme, Margareta Hellgren, et al.
Lakartidningen|November 10, 2011
[Hereditary antithrombin deficiency--rare, but serious. Great risk of venous thromboembolism]Katarina Bremme, Pia Petrini, Marie Sallamba, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 16, 2019
Obstetric and neonatal outcomes in pregnant women treated with high-dose thromboprophylaxis: a retrospective, single-center studyKatarina Bremme, Amelie Lannemyr, Lena Tyni, et al.
Lupus Science & Medicine|October 27, 2018
Obstetric antiphospholipid syndromeAleksandra Antovic, Maria Sennström, Katarina Bremme, et al.
Journal of Thrombosis and Haemostasis : JTH|July 3, 2020
Management and outcomes of newborns at risk for inherited antithrombin deficiencyRoza Chaireti, Ida Trönnhagen, Katarina Bremme, et al.
Lupus|April 12, 2021
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosusKatarina Bremme, Sonja Honkanen, Iva Gunnarsson, et al.
Thrombosis Research|August 20, 2014
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutationUlla Kjellberg, Marianne van Rooijen, Katarina Bremme, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Lakartidningen|January 29, 2020
[Program for clinical care of immune thrombocytopenic purpura in pregnancy]Gisela Wegnelius, Katarina Bremme, Pelle Lindqvist
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 3, 2015
Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsiaThomas Kahan, Katarina Bremme, Eva Östlund
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 12, 2018
Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practiceGisela Wegnelius, Katarina Bremme, Pelle G Lindqvist, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 15, 2011
Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolismPelle G Lindqvist, Katarina Bremme, Margareta Hellgren, et al.
Lakartidningen|November 10, 2011
[Hereditary antithrombin deficiency--rare, but serious. Great risk of venous thromboembolism]Katarina Bremme, Pia Petrini, Marie Sallamba, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 16, 2019
Obstetric and neonatal outcomes in pregnant women treated with high-dose thromboprophylaxis: a retrospective, single-center studyKatarina Bremme, Amelie Lannemyr, Lena Tyni, et al.
Lupus Science & Medicine|October 27, 2018
Obstetric antiphospholipid syndromeAleksandra Antovic, Maria Sennström, Katarina Bremme, et al.
Journal of Thrombosis and Haemostasis : JTH|July 3, 2020
Management and outcomes of newborns at risk for inherited antithrombin deficiencyRoza Chaireti, Ida Trönnhagen, Katarina Bremme, et al.
Lupus|April 12, 2021
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosusKatarina Bremme, Sonja Honkanen, Iva Gunnarsson, et al.
Thrombosis Research|August 20, 2014
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutationUlla Kjellberg, Marianne van Rooijen, Katarina Bremme, et al.
Pageof 7